Polifarma
Highly Engaged Employees
Manufacturing · Turkey · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Istanbul, TurkeyPhone Number
+90 2826751404Website
www.polifarma.com.trRevenue
$6 MillionIndustry
About Polifarma
Polifarma Org Chart
Is Polifarma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Polifarma
Earning: See what the market has to say on Polifarma recently announced quarterly report
Check if Polifarma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Polifarma has new funding data
Check out if Polifarma is spiking on competitors!
Polifarma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Polifarma had a recent Job posting/layoffs
Product Launch: Get notified when Polifarma launches new products
Recommended Actions
Reach out to Masked Content who joined Polifarma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Polifarma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Polifarma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Polifarma.
Polifarma Tech Stack
A closer look at the technologies used by Polifarma
Polifarma News & Media
Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has entered into an exclusive agreement with Polifarma Ilac San. ve tic. A.S. (“Polifarma”) for the commercialization in Turkey of AVT06, a proposed biosimilar to Eylea® (aflibercept).Dong-A ST Signs License-out Deal with Polifarma of Türkiye for NESP® Biosimilar DA-3880
SEOUL, South Korea--(BUSINESS WIRE)-- #ARANESP--Dong-A ST licenses out the rights for the development and commercialization of NESP® Biosimilar DA-3880 in Türkiye, Brazil and Mexico to Polifarma.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Polifarma
Polifarma is a leading pharmaceutical company focused on innovative solutions in drug development and production. They cater to the global healthcare market, emphasizing research and development to enhance treatment options. With a commitment to improving public health, Polifarma participates in major international pharmaceutical exhibitions to sho... Read More